These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rational antibiotics therapy in bacterial meningitis. Dutta AK; Bhatnagar SK Indian J Pediatr; 2001 Jul; 68 Suppl 3():S32-9. PubMed ID: 11980457 [TBL] [Abstract][Full Text] [Related]
24. [Our experiences with the use of corticosteroids in the treatment of purulent meningitis]. Kroó AH; Hallová D G Mal Infett Parassit; 1966 Nov; 18(11):744-50. PubMed ID: 5987224 [No Abstract] [Full Text] [Related]
25. Irreversible papillitis and ophthalmoparesis as a presenting manifestation of neurobrucellosis. Miyares FR; Deleu D; ElShafie SS; Equia F; Mesraoua B; Al Hail H; Salim K Clin Neurol Neurosurg; 2007 Jun; 109(5):439-41. PubMed ID: 17320277 [TBL] [Abstract][Full Text] [Related]
27. Is hearing assessed after bacterial meningitis? Fortnum HM; Hull D Arch Dis Child; 1992 Sep; 67(9):1111-2. PubMed ID: 1304733 [TBL] [Abstract][Full Text] [Related]
28. Rational basis of modern therapy of bacterial meningitis. Review of the literature and our clinical experience of 122 pediatric cases. Pecco P; Pavesio D; Peisino MG Panminerva Med; 1991; 33(4):185-90. PubMed ID: 1806876 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of post-meningitic cochlear injury with cerebrospinal fluid irrigation. Yeung AH; Tinling SP; Brodie HA Otolaryngol Head Neck Surg; 2006 Feb; 134(2):214-24. PubMed ID: 16455367 [TBL] [Abstract][Full Text] [Related]
30. [Supplemental treatment of bacterial meningitis with corticosteroids still insufficiently founded]. de Gans J; Enting R; Vermeulen M Ned Tijdschr Geneeskd; 1994 Jan; 138(4):172-5. PubMed ID: 8107915 [No Abstract] [Full Text] [Related]
31. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment. Klein M; Koedel U; Kastenbauer S; Pfister HW Infection; 2008 Feb; 36(1):2-14. PubMed ID: 18084715 [TBL] [Abstract][Full Text] [Related]
32. Benefit of glucocorticosteroid in the routine therapy of bacterial meningitis in children. Sébire G; Cyr C; Echenne B Eur J Paediatr Neurol; 2006 Jul; 10(4):163-6. PubMed ID: 16949844 [TBL] [Abstract][Full Text] [Related]
33. Could antioxidant therapy reduce the incidence of deafness following bacterial meningitis? Maurizi CP Med Hypotheses; 1999 Jan; 52(1):85-7. PubMed ID: 10342676 [TBL] [Abstract][Full Text] [Related]
34. [Importance of Corticosteroids in the treatment of infectious diseases (author's transl]. Kaiser H MMW Munch Med Wochenschr; 1982 Jan; 124(3):37-44. PubMed ID: 6283339 [No Abstract] [Full Text] [Related]
35. Corticosteroids in the treatment of skin disorders. O'Loughlin S Ir Med J; 1982 Mar; 75(3):69-71. PubMed ID: 7076468 [No Abstract] [Full Text] [Related]
36. [Corticosteroids in acute infectious diseases]. Kaiser H Munch Med Wochenschr; 1967 Dec; 109(48):2544-6 passim. PubMed ID: 5631904 [No Abstract] [Full Text] [Related]
37. [Pathophysiology of neuronal injury in bacterial meningitis and experimental adjunctive therapeutic approaches]. Böttcher T Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S7-9. PubMed ID: 19685399 [TBL] [Abstract][Full Text] [Related]
38. Topical corticosteroids. Gambrill J; Miller L Aust Fam Physician; 1984 Jan; 13(1):45-7. PubMed ID: 6370218 [TBL] [Abstract][Full Text] [Related]
39. A prospective investigation of the long-term auditory-neurological sequelae associated with bacterial meningitis: a study from Vanuatu. Carroll KJ; Carroll C J Trop Med Hyg; 1994 Jun; 97(3):145-50. PubMed ID: 8007054 [TBL] [Abstract][Full Text] [Related]